108 related articles for article (PubMed ID: 8902570)
1. Long-term follow-up of larynx leukoplakia under treatment with retinyl palmitate.
Issing WJ; Struck R; Naumann A
Head Neck; 1996; 18(6):560-5. PubMed ID: 8902570
[TBL] [Abstract][Full Text] [Related]
2. [High concentrate A-mulsin, a new therapy concept in laryngeal leukoplakia].
Issing WJ; Struck R; Naumann A; Kastenbauer E
Laryngorhinootologie; 1996 Jan; 75(1):29-33. PubMed ID: 8851116
[TBL] [Abstract][Full Text] [Related]
3. Positive impact of retinyl palmitate in leukoplakia of the larynx.
Issing WJ; Struck R; Naumann A
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S105-9. PubMed ID: 9065641
[TBL] [Abstract][Full Text] [Related]
4. High-dose cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx.
Lacava JA; Ferreyra R; Leone BA; Losada C; Elem YL; Vallejo CT
Cancer J Sci Am; 1996; 2(1):46-51. PubMed ID: 9166498
[TBL] [Abstract][Full Text] [Related]
5. Pilot phase IIA study for evaluation of the efficacy of folic acid in the treatment of laryngeal leucoplakia.
Almadori G; Bussu F; Navarra P; Galli J; Paludetti G; Giardina B; Maurizi M
Cancer; 2006 Jul; 107(2):328-36. PubMed ID: 16770770
[TBL] [Abstract][Full Text] [Related]
6. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
7. Chemo-immunotherapy in advanced head and neck cancer.
Recchia F; Sica G; De Filippis S; Rosselli M; Pompili P; Saggio G; Rea S
Anticancer Res; 1999; 19(1B):773-7. PubMed ID: 10216492
[TBL] [Abstract][Full Text] [Related]
8. Plasma kinetics of oral retinol in cancer patients.
Goodman GE; Alberts DS; Peng YM; Beaudry J; Leigh SA; Moon TE
Cancer Treat Rep; 1984 Sep; 68(9):1125-33. PubMed ID: 6478452
[TBL] [Abstract][Full Text] [Related]
9. Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer.
Recchia F; Sica G; De Filippis S; Rea S; Frati L
Anticancer Res; 1997; 17(5B):3761-5. PubMed ID: 9427776
[TBL] [Abstract][Full Text] [Related]
10. The role of acid and alkaline reflux in laryngeal squamous cell carcinoma.
Galli J; Cammarota G; Calò L; Agostino S; D'Ugo D; Cianci R; Almadori G
Laryngoscope; 2002 Oct; 112(10):1861-5. PubMed ID: 12368631
[TBL] [Abstract][Full Text] [Related]
11. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis.
Lippman SM; Batsakis JG; Toth BB; Weber RS; Lee JJ; Martin JW; Hays GL; Goepfert H; Hong WK
N Engl J Med; 1993 Jan; 328(1):15-20. PubMed ID: 8416267
[TBL] [Abstract][Full Text] [Related]
12. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
13. Positive therapy of andrographolide in vocal fold leukoplakia.
Xu J; Xue T; Bao Y; Wang DH; Ma BL; Yin CY; Yang GH; Ren G; Lan LJ; Wang JQ; Zhang XL; Zhao YQ
Am J Otolaryngol; 2014; 35(2):77-84. PubMed ID: 24444776
[TBL] [Abstract][Full Text] [Related]
14. Initial experience in the treatment of oral leukoplakia with high-dose vitamin A and follow-up 5-aminolevulinic acid induced protoporphyrin IX fluorescence.
Leunig A; Betz CS; Baumgartner R; Grevers G; Issing WJ
Eur Arch Otorhinolaryngol; 2000; 257(6):327-31. PubMed ID: 10993553
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
[TBL] [Abstract][Full Text] [Related]
17. [Induction chemotherapy and larynx preservation: is such practice useful?].
Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
[TBL] [Abstract][Full Text] [Related]
18. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly.
Allal AS; Maire D; Becker M; Dulguerov P
Cancer; 2000 Feb; 88(3):648-52. PubMed ID: 10649260
[TBL] [Abstract][Full Text] [Related]
20. Effects of limited doses of retinyl palmitate at the critical time of limb morphogenesis in mouse embryos.
Rezaei N; Hashemi Soteh MB; Rahimi F
Indian J Exp Biol; 2009 Dec; 47(12):949-54. PubMed ID: 20329697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
